Metraipolis › archive › dc_5f28e27c466d

Pharmacologic management of HR+/HER2- mBC: a clinically oriented review — Europe PMC PMID:40989687

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40989687
DOI
10.3389/fonc.2025.1596634
License (as archived)
solo-consultazione
Archived
2026-11-10T01:44:51.192Z
SHA-256 of the archived text
67f039ac5eb31cb00c30260eb31414309385a7d6d77d75c071ae5d94e05f6bc2
Stable URL of this page
https://metraipolis.com/documento/dc_5f28e27c466d

How to cite

Pharmacologic management of HR+/HER2- mBC: a clinically oriented review — Europe PMC PMID:40989687 — Europe PMC (en), https://europepmc.org/article/MED/40989687 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5f28e27c466d (Metraipolis archive dc_5f28e27c466d, sha256 67f039ac5eb31cb00c30260eb31414309385a7d6d77d75c071ae5d94e05f6bc2)
BibTeX
@misc{dc5f28e27c466d,
  title = {Pharmacologic management of HR+/HER2- mBC: a clinically oriented review — Europe PMC PMID:40989687},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40989687},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5f28e27c466d; sha256 67f039ac5eb31cb00c30260eb31414309385a7d6d77d75c071ae5d94e05f6bc2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40989687. Agents can read the archived copy with the MCP tool read_document.